Cardiovascular mortality in bipolar disorder: Population-based cohort study

IF 5.3 2区 医学 Q1 PSYCHIATRY Acta Psychiatrica Scandinavica Pub Date : 2024-06-03 DOI:10.1111/acps.13715
Tapio Paljärvi, Kimmo Herttua, Heidi Taipale, Markku Lähteenvuo, Antti Tanskanen, Jari Tiihonen
{"title":"Cardiovascular mortality in bipolar disorder: Population-based cohort study","authors":"Tapio Paljärvi,&nbsp;Kimmo Herttua,&nbsp;Heidi Taipale,&nbsp;Markku Lähteenvuo,&nbsp;Antti Tanskanen,&nbsp;Jari Tiihonen","doi":"10.1111/acps.13715","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Limited evidence base on cause-specific excess cardiovascular disease (CVD) mortality in bipolar disorder (BD) is a barrier to developing preventive interventions aimed at reducing the persistent mortality gap in BD.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To investigate cause-specific CVD mortality in BD.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We identified all individuals aged 15+ years during 2004–2018 with a diagnosis of BD using Finnish nationwide routine data. Standardised mortality ratios (SMR) with 95% confidence intervals (CI) were calculated using the mortality rates in the general population as weights.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>53,273 individuals with BD (57% women; median age at BD diagnosis, 40 years), were followed up for 428,426 person-years (median, 8.2 years). There were 5988 deaths due to any cause, of which 26% were due to CVD. The leading cause of absolute excess CVD mortality was coronary artery disease (CAD). The leading causes of relative excess mortality were cardiomegaly (SMR, 4.51; 95% CI, 3.58–5.43), venous thromboembolism (3.03; 2.26–3.81), cardiomyopathy (2.46; 1.95–2.97), and hypertensive heart disease (2.12; 1.71–2.54). The leading causes of absolute CVD mortality showed markedly lower relative excess, including CAD (1.47; 1.34–1.61), ischaemic stroke (1.31; 1.06–1.54), and acute myocardial infarction (1.12; 0.98–1.25). Due to the higher relative excess mortality, structural and functional heart disorders contributed as much as atherosclerotic and ischaemic disorders to the absolute excess mortality.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Cardiomyopathy and hypertensive heart disease as the leading causes of relative excess mortality emphasise the contribution of structural and functional heart disorders to the overall excess mortality alongside coronary artery disease. Interventions targeted at these modifiable causes of death should be priorities in the prevention of premature excess CVD mortality in BD.</p>\n </section>\n </div>","PeriodicalId":108,"journal":{"name":"Acta Psychiatrica Scandinavica","volume":"150 2","pages":"56-64"},"PeriodicalIF":5.3000,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Psychiatrica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/acps.13715","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Limited evidence base on cause-specific excess cardiovascular disease (CVD) mortality in bipolar disorder (BD) is a barrier to developing preventive interventions aimed at reducing the persistent mortality gap in BD.

Objective

To investigate cause-specific CVD mortality in BD.

Methods

We identified all individuals aged 15+ years during 2004–2018 with a diagnosis of BD using Finnish nationwide routine data. Standardised mortality ratios (SMR) with 95% confidence intervals (CI) were calculated using the mortality rates in the general population as weights.

Results

53,273 individuals with BD (57% women; median age at BD diagnosis, 40 years), were followed up for 428,426 person-years (median, 8.2 years). There were 5988 deaths due to any cause, of which 26% were due to CVD. The leading cause of absolute excess CVD mortality was coronary artery disease (CAD). The leading causes of relative excess mortality were cardiomegaly (SMR, 4.51; 95% CI, 3.58–5.43), venous thromboembolism (3.03; 2.26–3.81), cardiomyopathy (2.46; 1.95–2.97), and hypertensive heart disease (2.12; 1.71–2.54). The leading causes of absolute CVD mortality showed markedly lower relative excess, including CAD (1.47; 1.34–1.61), ischaemic stroke (1.31; 1.06–1.54), and acute myocardial infarction (1.12; 0.98–1.25). Due to the higher relative excess mortality, structural and functional heart disorders contributed as much as atherosclerotic and ischaemic disorders to the absolute excess mortality.

Conclusions

Cardiomyopathy and hypertensive heart disease as the leading causes of relative excess mortality emphasise the contribution of structural and functional heart disorders to the overall excess mortality alongside coronary artery disease. Interventions targeted at these modifiable causes of death should be priorities in the prevention of premature excess CVD mortality in BD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
双相情感障碍的心血管死亡率:基于人群的队列研究。
背景:有关双相情感障碍(BD)中心血管疾病(CVD)特异性超额死亡率的证据基础有限,这阻碍了旨在减少双相情感障碍中持续存在的死亡率差距的预防性干预措施的制定:调查双相情感障碍患者心血管疾病死亡率的具体原因:我们利用芬兰全国范围内的常规数据,对 2004-2018 年间所有年龄在 15 岁以上、诊断为 BD 的患者进行了识别。以普通人群的死亡率为权重,计算标准化死亡率(SMR)及95%置信区间(CI):对 53273 名 BD 患者(57% 为女性;BD 诊断年龄中位数为 40 岁)进行了 428426 人年(中位数为 8.2 年)的随访。共有5988人死于任何原因,其中26%死于心血管疾病。心血管疾病绝对超额死亡率的主要原因是冠状动脉疾病(CAD)。导致相对超额死亡率的主要原因是心肌肥大(SMR,4.51;95% CI,3.58-5.43)、静脉血栓栓塞(3.03;2.26-3.81)、心肌病(2.46;1.95-2.97)和高血压性心脏病(2.12;1.71-2.54)。心血管疾病绝对死亡率的主要原因显示出明显较低的相对超额死亡率,包括 CAD(1.47;1.34-1.61)、缺血性中风(1.31;1.06-1.54)和急性心肌梗死(1.12;0.98-1.25)。由于相对超额死亡率较高,结构性和功能性心脏疾病与动脉粥样硬化和缺血性疾病对绝对超额死亡率的影响一样大:结论:心肌病和高血压性心脏病是导致相对超额死亡率的主要原因,这强调了结构性和功能性心脏疾病与冠状动脉疾病对总体超额死亡率的贡献。针对这些可改变的死因的干预措施应成为预防BD过早超额心血管疾病死亡率的优先事项。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Psychiatrica Scandinavica
Acta Psychiatrica Scandinavica 医学-精神病学
CiteScore
11.20
自引率
3.00%
发文量
135
审稿时长
6-12 weeks
期刊介绍: Acta Psychiatrica Scandinavica acts as an international forum for the dissemination of information advancing the science and practice of psychiatry. In particular we focus on communicating frontline research to clinical psychiatrists and psychiatric researchers. Acta Psychiatrica Scandinavica has traditionally been and remains a journal focusing predominantly on clinical psychiatry, but translational psychiatry is a topic of growing importance to our readers. Therefore, the journal welcomes submission of manuscripts based on both clinical- and more translational (e.g. preclinical and epidemiological) research. When preparing manuscripts based on translational studies for submission to Acta Psychiatrica Scandinavica, the authors should place emphasis on the clinical significance of the research question and the findings. Manuscripts based solely on preclinical research (e.g. animal models) are normally not considered for publication in the Journal.
期刊最新文献
More rTMS pulses or more sessions? The impact on treatment outcome for treatment resistant depression. Letter to the Editor Concerning "Glucagon-Like Peptide Agonists for Weight Management in Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis". Prediction of electroconvulsive therapy outcome: A network analysis approach. How to treat antipsychotic-related weight gain and metabolic disturbances: Is there a role for GLP-1 receptor agonists? Issue Information
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1